stockrowInfuSystems Holdings, Inc. (INFU) vs TriSalus Life Sciences, Inc. (TLSI)
- InfuSystems Holdings, Inc. INFU 13.73 +1.25%
- TriSalus Life Sciences, Inc. TLSI 3.26 −7.65%
InfuSystems Holdings, Inc. and TriSalus Life Sciences, Inc. are both Medical Devices companies. InfuSystems Holdings, Inc. is the larger, with a market value of $270.1M against $217.4M — 1.2× the size. TriSalus Life Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; InfuSystems Holdings, Inc. trades at 32.7×. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against 2.47%. InfuSystems Holdings, Inc. has the higher net margin (5.96% vs −130.2%) and the higher return on invested capital (10.6% vs 0.00%). Across the 18 metrics below, InfuSystems Holdings, Inc. leads on 12 and TriSalus Life Sciences, Inc. on 6.
Valuation
Profitability
| Metric | INFU | TLSI | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.45% | 85.79% | 57.76% |
| Operating margin | 9.26% | (67.68%) | (14.84%) |
| Net margin | 5.96% | (130.17%) | (14.45%) |
| Free cash flow margin | 10.56% | (51.56%) | (5.70%) |
| Return on equity | 15.03% | 911.60% | (10.56%) |
| Return on assets | 8.61% | (113.09%) | (17.26%) |
| Return on invested capital | 10.55% | 0.00% | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack